Third Rock Ventures's book
12 companies · priced by our data| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Seaport Therapeutics | — | $740.0M | — | — | |
| Candid Therapeutics | Drug Discovery | $657.0M | — | — | |
| Marea | — | $272.0M | — | — | |
| Merida Biosciences | Biotech | $228.0M | — | — | |
| Clasp Therapeutics | — | $191.5M | — | — | |
| ARTBIO | — | $190.0M | — | — | |
| Azalea Therapeutics | Biotechnology | $153.0M | — | — | |
| Corvia | — | $105.2M | — | — | |
| Abata Therapeutics | — | — | — | — | |
| YourBio Health | — | — | — | — | |
| + 2 more companies · a free account shows the top 25 | |||||
Free account
See the whole book
- ·The book's top 25 — of 12 recorded positions
- ·Watchlist + alerts for Third Rock Ventures's activity
Create free account
No card required